These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 39211545
1. Dual effect of N-terminal deletion of cardiac myosin essential light chain in mitigating cardiomyopathy. Sitbon YH, Kazmierczak K, Liang J, Kloehn AJ, Vinod J, Kanashiro-Takeuchi R, Szczesna-Cordary D. iScience; 2024 Aug 16; 27(8):110591. PubMed ID: 39211545 [Abstract] [Full Text] [Related]
2. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin. Sitbon YH, Diaz F, Kazmierczak K, Liang J, Wangpaichitr M, Szczesna-Cordary D. J Gen Physiol; 2021 Jul 05; 153(7):. PubMed ID: 34014247 [Abstract] [Full Text] [Related]
3. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice. Sitbon YH, Kazmierczak K, Liang J, Yadav S, Veerasammy M, Kanashiro-Takeuchi RM, Szczesna-Cordary D. FEBS J; 2020 Sep 05; 287(18):3989-4004. PubMed ID: 32034976 [Abstract] [Full Text] [Related]
4. Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations. Kazmierczak K, Yuan CC, Liang J, Huang W, Rojas AI, Szczesna-Cordary D. Front Physiol; 2014 Sep 05; 5():353. PubMed ID: 25295008 [Abstract] [Full Text] [Related]
5. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM. Kazmierczak K, Liang J, Maura LG, Scott NK, Szczesna-Cordary D. Life (Basel); 2023 Jun 28; 13(7):. PubMed ID: 37511838 [Abstract] [Full Text] [Related]
6. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations. Huang W, Szczesna-Cordary D. J Muscle Res Cell Motil; 2015 Dec 28; 36(6):433-45. PubMed ID: 26385864 [Abstract] [Full Text] [Related]
7. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice. Yuan CC, Kazmierczak K, Liang J, Kanashiro-Takeuchi R, Irving TC, Gomes AV, Wang Y, Burghardt TP, Szczesna-Cordary D. Cardiovasc Res; 2017 Aug 01; 113(10):1124-1136. PubMed ID: 28371863 [Abstract] [Full Text] [Related]
8. The role of the N-terminus of the myosin essential light chain in cardiac muscle contraction. Kazmierczak K, Xu Y, Jones M, Guzman G, Hernandez OM, Kerrick WG, Szczesna-Cordary D. J Mol Biol; 2009 Apr 03; 387(3):706-25. PubMed ID: 19361417 [Abstract] [Full Text] [Related]
9. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy. Kazmierczak K, Paulino EC, Huang W, Muthu P, Liang J, Yuan CC, Rojas AI, Hare JM, Szczesna-Cordary D. Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H575-89. PubMed ID: 23748425 [Abstract] [Full Text] [Related]
10. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction. Muthu P, Wang L, Yuan CC, Kazmierczak K, Huang W, Hernandez OM, Kawai M, Irving TC, Szczesna-Cordary D. FASEB J; 2011 Dec 15; 25(12):4394-405. PubMed ID: 21885653 [Abstract] [Full Text] [Related]
11. Single cardiac ventricular myosins are autonomous motors. Wang Y, Yuan CC, Kazmierczak K, Szczesna-Cordary D, Burghardt TP. Open Biol; 2018 Apr 15; 8(4):. PubMed ID: 29669825 [Abstract] [Full Text] [Related]
12. Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains. Gomes AV, Kazmierczak K, Cheah JX, Gilda JE, Yuan CC, Zhou Z, Szczesna-Cordary D. J Muscle Res Cell Motil; 2015 Dec 15; 36(6):447-61. PubMed ID: 26668058 [Abstract] [Full Text] [Related]
15. Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations. Wang L, Muthu P, Szczesna-Cordary D, Kawai M. J Muscle Res Cell Motil; 2013 May 15; 34(2):93-105. PubMed ID: 23397074 [Abstract] [Full Text] [Related]
16. Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin. Yuan CC, Kazmierczak K, Liang J, Ma W, Irving TC, Szczesna-Cordary D. Proc Natl Acad Sci U S A; 2022 Feb 22; 119(8):. PubMed ID: 35177471 [Abstract] [Full Text] [Related]
17. Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load. Karabina A, Kazmierczak K, Szczesna-Cordary D, Moore JR. Arch Biochem Biophys; 2015 Aug 15; 580():14-21. PubMed ID: 26116789 [Abstract] [Full Text] [Related]
18. Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca(2+) sensitivity and cross-bridge detachment kinetics. Michael JJ, Gollapudi SK, Ford SJ, Kazmierczak K, Szczesna-Cordary D, Chandra M. Am J Physiol Heart Circ Physiol; 2013 Jan 15; 304(2):H253-9. PubMed ID: 23144314 [Abstract] [Full Text] [Related]
19. The N-terminus of A1-type myosin essential light chains binds actin and modulates myosin motor function. Timson DJ, Trayer HR, Trayer IP. Eur J Biochem; 1998 Aug 01; 255(3):654-62. PubMed ID: 9738905 [Abstract] [Full Text] [Related]
20. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice. Yuan CC, Muthu P, Kazmierczak K, Liang J, Huang W, Irving TC, Kanashiro-Takeuchi RM, Hare JM, Szczesna-Cordary D. Proc Natl Acad Sci U S A; 2015 Jul 28; 112(30):E4138-46. PubMed ID: 26124132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]